3D-printed medications

Readingtime 2 minutes

They are round, oval or rectangular, colorful or white—the structured tablets from the US company Laxxon Medical, in which Evonik Venture Capital recently invested. Laxxon simply prints out the pills using a new type of 3D screen printing technology. The multi-layer structure enables the controlled release of the active pharmaceutical ingredients over an extended period of time. In addition, several ingredients can be combined with each other in this way. Polymers from Evonik ensure the targeted release of the active ingredients. “The technology is a great benefit for patients,” says Bernhard Mohr, the head of Evonik Venture Capital. “It reduces side effects and the number of tablets a patient has to take. This lowers the risk of forgetting an important medication.”

Photo: Laxxon Medical GmbH

Pharma Polymers

Transport without Side Effects

Drug delivery—on the art of transporting active pharmaceutical ingredients to specific targets in the human body.


Robust and fast-dissolving

ODTs are practical, but they crumble easily. The auxiliary material RXCIPIENTS improves their properties.


Drug delivery

Transportation via polymers

Evonik and Stanford University are cooperating in a search for new carrier substances for mRNA vaccines.


Growth thanks to biotechnology

Is biotechnology a booster for the economy? Which sectors are benefiting from these innovations? An outlook in figures.

ELEMENTS Newsletter
Get fascinating insights into the research Evonik is conducting, and its social relevance, by subscribing to our free newsletter.